InvestSMART

Patrys Limited (ASX: PAB) - Announcements

- Current share price for PAB : $0.035

ASX company news and announcements for Patrys Limited (PAB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Patrys Limited (PAB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Patrys Limited (PAB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Patrys Limited (PAB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Proposed issue of securities - PAB 9 Jun 2026 8:28AM $0.042 $0.035 fallen by 16.67%
$23 Results of Meeting 9 Jun 2026 8:26AM $0.042 $0.035 fallen by 16.67%
$23 Patrys advances RLS-2202 toward Phase 1 Clinical Trial 20 May 2026 9:31AM $0.032 $0.035 risen by 9.38%
$23 Appendix 4C - Quarterly - 31 March 2026 - Updated 15 May 2026 6:20PM $0.031 $0.035 risen by 12.90%
$23 Letter to Shareholders - General Meeting 6 May 2026 8:17AM $0.029 $0.035 risen by 20.69%
$23 Notice of General Meeting/Proxy Form 6 May 2026 8:17AM $0.029 $0.035 risen by 20.69%
$23 Appendix 4C - Quarterly - 31 March 2026 30 Apr 2026 9:13AM $0.031 $0.035 risen by 12.90%
$23 Cleansing Notice 29 Apr 2026 8:48AM $0.030 $0.035 risen by 16.67%
$23 Application for quotation of securities - PAB 29 Apr 2026 8:44AM $0.030 $0.035 risen by 16.67%
$23 Proposed issue of securities - PAB 20 Apr 2026 9:31AM $0.026 $0.035 risen by 34.62%
$23 $3.2 million Placement to Advance Clinical Trials 20 Apr 2026 9:31AM $0.026 $0.035 risen by 34.62%
$23 Trading Halt 16 Apr 2026 8:53AM $0.026 $0.035 risen by 34.62%
$23 Investor Presentation - Broker Meets Biotech 31 Mar 2026 8:21AM $0.028 $0.035 risen by 25%
$23 Notification of cessation of securities - PAB 18 Mar 2026 7:36PM $0.032 $0.035 risen by 9.38%
$23 Change of Share Registry Details 13 Mar 2026 6:34PM $0.032 $0.035 risen by 9.38%
$23 RLS-2201 Manufacturing and Regulatory Pathway Initiated 11 Mar 2026 8:23AM $0.034 $0.035 risen by 2.94%
$23 Appendix 4D - Half Year Accounts - 31 December 2025 26 Feb 2026 6:12PM $0.040 $0.035 fallen by 12.50%
$23 CEO Commences Role 16 Feb 2026 8:13AM $0.035 $0.035 fallen by 0%
$23 Appointment of Chief Executive Officer 12 Feb 2026 8:13AM $0.037 $0.035 fallen by 5.41%
$23 Change of Director's Interest Notice - BL 10 Feb 2026 7:17PM $0.035 $0.035 fallen by 0%
$23 Cleansing Notice 10 Feb 2026 7:11PM $0.035 $0.035 fallen by 0%
$23 Notification regarding unquoted securities - PAB 10 Feb 2026 7:10PM $0.035 $0.035 fallen by 0%
$23 Application for quotation of securities - PAB 10 Feb 2026 7:05PM $0.035 $0.035 fallen by 0%
$23 Initial Director's Interest Notice x2 2 Feb 2026 6:31PM $0.034 $0.035 risen by 2.94%
$23 Appendix 4C - Quarterly - 31 December 2025 30 Jan 2026 8:17AM $0.033 $0.035 risen by 6.06%

1 - 25 of 668 results

Page 1 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.